Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 648 pembrolizumab 606 Magnetic Resonance Spectroscopy 559 Carboplatin 446 Cyclophosphamide 394 Cisplatin 394 Biopsy 376 Nivolumab 325 Paclitaxel 324 Gemcitabine 317 Radiotherapy 295 Bevacizumab 245 Dexamethasone 224 fludarabine 214 Docetaxel 202 durvalumab 194 Oxaliplatin 191 venetoclax 187 atezolizumab 179 Fluorouracil 179 Rituximab 174 Capecitabine 170 Pemetrexed 169 Radiation 164 Doxorubicin 164 Radiosurgery 161 Ipilimumab 148 Lenalidomide 143 Leucovorin 139 Etoposide 139

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lysine × 90 days × Clear all

NCT07150806 2026-05-22

RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma

Ohio State University Comprehensive Cancer Center

Phase 1/2 Recruiting

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡